News & Events
cDSI helps doctors decide which Alzheimer’s patients are appropriate for lumbar puncture
Alzheimer’s proteins in the cerebrospinal fluid play an increasingly important role in an accurate diagnosis. In this article, Dr. Hanneke Rhodius-Meester of the Alzheimer Center Amsterdam explains how cDSI can help doctors decide which patients are appropriate for a lumbar puncture.
RSNA 2019
Attending RSNA 2019? Speak with one of our team members at booth 10532B during the show.
Combinostics raises €3.9M to support early Alzheimer’s diagnosis
Combinostics is pleased to announce the closure of a €3.9M series A funding round to extend the company’s cNeuro platform in the US and Asia.
Combinostics partners with Nihon Medi-Physics to develop and market cNeuro platform in Japan
Combinostics is pleased to announce an exclusive partnership with Nihon Medi-Physics to develop and market the cNeuro platform in Japan.
Three peer-reviewed, scientific publications that describe the use of cNeuro
Three peer-reviewed, scientific journals have published articles that describe the use of the cNeuro platform for dementias and other cognitive disorders.
Combinostics selected to join the 2019 MassChallenge HealthTech cohort
Combinostics has been selected to join the 2019 MassChallenge HealthTech cohort which represents the most innovative technologies advancing health and improving the overall patient experience.
RSNA 2018
Attending RSNA 2018? Speak with one of our team members at kiosk 7367M in the North – Hall.
